← Back to news

Markets

Micron put buyer realizes 39% same-day gains

Y

AI Is Transforming This Once-Boring Blue-Chip Stock. Is It a Buy for 2026?

Y

FrontView REIT price target raised to $14 from $13.50 at Morgan Stanley

Y

Dow Jones Futures: Market Shut, Faces Test To Start 2026; Tesla Deliveries, Musk Deadline In Focus

Y

Jeffs’ Brands says Fort Technology intends to list on Nasdaq Capital Market

Y

Limoneira assumed with a Buy at Lake Street

Y

3 High-Conviction AI Stocks With 10x Potential by 2036

Y

Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy.

Y

NextEra Energy price target raised to $88 from $85 at Jefferies

Y

Thiel Capital, founded by billionaire Peter Thiel, opens a new office in Miami as California debates a wealth tax

Y

This Is How I Would Invest $100,000 In 2026

S

Ray Dalio warned America’s in a ‘debt death spiral’, with US dollar at risk. Here’s the shockproof asset he recommends

Y

The Most Overlooked Stock That’s Worthy of Your Attention Now Heading Into 2026

Y

The Fed's Biggest Problem Is The Market's Greatest Advantage

S

Is the Vanguard Russell 2000 Index Fund ETF a Buy Now?

Y

Labrador Gold acquires subscription receipts of Northern Shield

Y

‘Anyone can do it’: This 30-year-old quit her job for a side hustle that now brings in seven figures a year. Here’s how

Y

Highlander Silver announces planned NYSE American listing in Q1

Y

This is how much the average employed baby boomer has saved for retirement. How do you stack up?

Y

My Most Important Dividend Growth Picks For The Market's Next Phase

S

Is Palantir Technologies Stock a Buy?

Y

This Ramsey Show caller is nearly retired with $4K saved. Should she borrow against her home? What the hosts had to say

Y

This Is the First Thing Retirement Savers Should Do in 2026

Y

5 States Where the Top 1% Pay the Least in Taxes

Y

Tether Starts 2026 With an $800M Bitcoin Buy, Quietly Joins Top Holders — Here's How Much They Hold

Y

Is Coinbase Global (COIN) One of the Best NASDAQ Stocks to Buy in 2026?

Y

Citi Maintains Neutral Outlook on Monday.com (MNDY) Amid Stable but Uncertain Software Demand

Y

H.C. Wainwright: BioMarin’s (BMRN) Amicus Acquisition Stabilizes Cash Flow While Voxzogo Remains Near-Term Driver

Y

Truist Maintains Hold on Zebra Technologies (ZBRA) While Lowering PT Amid Scrutiny of 2026 Demand

Y

Jefferies Urges Selectivity on Duolingo (DUOL) as AI Disintermediation Risks and High Spending Threaten 2026 Valuations

Y

DA Davidson: Vital Farms (VITL) Positioned for 2026 Growth as Operational Recovery Outshines Temporary Q4 Guidance Miss

Y

Morgan Stanley Cuts Tenable (TENB) PT as Cybersecurity Platform Giants Outpace Best-Of-Breed Peers

Y

JPMorgan Maintains Overweight on Oddity Tech (ODD) While Reducing PT Following 2026 Sector Forecast

Y

Wells Fargo Maintains Overweight on Masimo (MASI) Following Investor Day Confidence In Long-Range Revenue Targets

Y

Power Solutions (PSIX) International Set for Valuation Growth on Data Center Demand and Infrastructure Shifts

Y

MannKind Corporation (MNKD) Secures FDA Approval for FUROSCIX Pediatric Use, Expanding Reach In Heart, Kidney Disease Care

Y

Nvidia Buys Intel Corporation’s (INTC) Shares Worth $5 Billion, Here’s What You Need to Know

Y

Corning Incorporated (GLW) Up More Than 70% in 6 Months, Here’s What You Need to Know

Y

Wall Street Bullish on Lam Research Corporation (LRCX), Here’s What You Need to Know

Y

Here’s What Wall Street Thinks About Unity Software Inc. (U)

Y

Seagate Technology Holdings (STX) Has Gained More Than 98% Over the Past 6 Months, Here’s What You Need to Know

Y

MongoDB, Inc. (MDB) Trading Close to 52-Week High, Here’s What Analysts Think About It

Y

Here’s What Wall Street Thinks About Coherent Corp. (COHR)

Y

Here’s Why BofA Has a Buy Rating on Teradyne, Inc. (TER)

Y

Tesla Sales Outlook Darkens Despite Musk’s Self-Driving Euphoria

Y

Sysco Is A Needle In A Haystack For Value Investors

S

Dell Technologies' Business Could Be Hurt By Surging Memory Prices

S

Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook

S

Merck: Framework For Success

S

Viking Therapeutics: A Wide-Open Oral GLP-1 Market

S